All‐cause mortality · patients with laparoscopic cholecystectomy.
1 finding from 1 review
Serious adverse events · patients with laparoscopic cholecystectomy.
It is very uncertain whether low pressure changes serious adverse events compared with standard pressure pneumoperitoneum (very low certainty).
1 finding from 1 review
Conversion to open cholecystectomy · patients with laparoscopic cholecystectomy.
It is very uncertain whether low pressure changes conversion to open cholecystectomy compared with standard pressure pneumoperitoneum (very low certainty).
1 finding from 1 review
Length of hospital stay · patients with laparoscopic cholecystectomy.
1 finding from 1 review
Operating time · patients with laparoscopic cholecystectomy.
1 finding from 1 review
All‐cause mortality: at 3 years · primary hepatocellular carcinoma
TACE followed by 3‐DCRT may leads to lower all‐cause mortality: at 3 years compared with TACE (low certainty).
1 finding from 1 review
Proportion of participants without tumour response (CR+PR) · primary hepatocellular carcinoma
TACE followed by 3‐DCRT may leads to lower proportion of participants without tumour response (CR+PR) compared with TACE (low certainty).
1 finding from 1 review
Serious adverse events · primary hepatocellular carcinoma
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Health‐related quality of life · primary hepatocellular carcinoma
1 finding from 1 review
Non‐serious adverse events: leukopenia · primary hepatocellular carcinoma
It is very uncertain whether TACE followed by 3‐DCRT changes non‐serious adverse events: leukopenia compared with TACE (very low certainty).
1 finding from 1 review
Non‐serious adverse events: serum transaminases elevation · primary hepatocellular carcinoma
It is very uncertain whether TACE followed by 3‐DCRT changes non‐serious adverse events: serum transaminases elevation compared with TACE (very low certainty).
1 finding from 1 review
Non‐serious adverse events: total bilirubin elevation · primary hepatocellular carcinoma
It is very uncertain whether TACE followed by 3‐DCRT changes non‐serious adverse events: total bilirubin elevation compared with TACE (very low certainty).
1 finding from 1 review
Proportion of participants without serum AFP normalisation · primary hepatocellular carcinoma
It is very uncertain whether TACE followed by 3‐DCRT changes proportion of participants without serum AFP normalisation compared with TACE (very low certainty).
1 finding from 1 review
Ischaemic biliary complications (donated following brain death (DBD)) · liver transplant recipients
Hypothermic oxygenated perfusion (HOPE) showed no clear difference in ischaemic biliary complications (donated following brain death (DBD)) compared with static cold storage (SCS); GRADE not reported.
1 finding from 1 review
Ischaemic biliary complications (donated following circulatory death (DCD)) · liver transplant recipients
Hypothermic oxygenated perfusion (HOPE) led to lower ischaemic biliary complications (donated following circulatory death… compared with static cold storage (SCS); GRADE not reported.
1 finding from 1 review
Intervention not reported
Participants with any complication: up to 3 months following randomisation · participants with alcoholic hepatitis at high risk of mortality and morbidity
It is very uncertain whether the intervention changes participants with any complication: up to 3 months following… (very low certainty).
1 finding from 1 review
Intervention not reported
There was no evidence of differences in the proportion of participants experiencing serious adverse events (for any of the comparisons Quality of evidence = very low1,2,3. · people undergoing liver resection
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
There was no evidence of differences in the number of serious adverse events for any of the comparisons Quality of evidence = very low1,2,3. · people undergoing liver resection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number requiring allogeneic blood transfusion ‐ Low central venous pressure (CVP) versus control. · patients with liver resection.
It is very uncertain whether the intervention changes number requiring allogeneic blood transfusion ‐ Low central venous… (very low certainty).
1 finding from 1 review
Intervention not reported
Red cell transfusion ‐ Low CVP versus control. · patients with liver resection.
1 finding from 1 review